Alpha Mark Advisors, LLC Corcept Therapeutics Inc Transaction History
Alpha Mark Advisors, LLC
- $290 Million
- Q3 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 9,739 shares of CORT stock, worth $512,466. This represents 0.16% of its overall portfolio holdings.
Number of Shares
9,739
Previous 411
2269.59%
Holding current value
$512,466
Previous $13,000
3369.23%
% of portfolio
0.16%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
347Shares Held
86.6MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$870 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$527 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$435 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$343 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$201 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.64B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...